Center for Scientific Review; Notice of Closed Meeting, 15714-15715 [2010-6957]

Download as PDF 15714 Federal Register / Vol. 75, No. 60 / Tuesday, March 30, 2010 / Notices DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration [Docket No. FDA–2010–N–0001] Voting and Nonvoting Consumer Representative Members on Public Advisory Committees and Panels; Notice of Public Meeting AGENCY: Food and Drug Administration, HHS. jlentini on DSKJ8SOYB1PROD with NOTICES ACTION: Notice of public meeting. The Food and Drug Administration (FDA) is announcing a public meeting for individuals and groups interested in nominating voting and nonvoting consumer representatives to FDA advisory committees and panels. This public meeting also is for individuals interested in serving as voting and nonvoting representatives of FDA advisory committees and panels. The purpose of the public meeting is to inform individuals and groups with consumer interests on how to participate in the nomination and selection process for members representing consumer interests on advisory committees, provide information on the structure and function of advisory committees seeking individuals to serve as consumer representatives, and update individuals and consumer groups and individuals on current committee vacancies. Date and Time: The public meeting will be held on April 30, 2010, from 8:15 a.m. to approximately 4:30 p.m. Location: The public meeting will be held at the Food and Drug Administration, Center for Drug Evaluation and Research Advisory Committee Conference Room, rm. 1066, 5630 Fishers Lane, Rockville, MD. Please use the lower entrance, which faces Parklawn Drive. Visitor badges will be held at the guard station at the entrance to the building. Participants will need a picture identification to pick up their badge. Public parking is not available at the 5630 Fishers Lane location. A public parking lot is available on Fishers Lane across from the Parklawn Building at 5600 Fishers Lane, and additional public parking is available at the Twinbrook Metro Station located several blocks west of the meeting location. Contact Person: Doreen Brandes, Office of the Commissioner (HF–4), Food and Drug Administration, 5600 Fishers Lane, Rockville, MD 20857, 301–827–8858, FAX: 301–827–1041, or e-mail: Doreen.Brandes@fda.hhs.gov. After April 15, 2010, the contact person’s location and contact VerDate Nov<24>2008 16:22 Mar 29, 2010 Jkt 220001 information will change. All correspondence should be mailed to Doreen Brandes, Office of the Commissioner, 10903 New Hampshire Ave., Bldg. 32, rm. 5103, Silver Spring, MD 20993–0002, 301–796–8858, FAX: 301–847–8640, or e-mail: Doreen.Brandes@fda.hhs.gov. Registration: Register by e-mail or fax to the contact person no later than April 23, 2010. Provide complete information for each attendee, including name, title, organization’s name, address, e-mail, and telephone and fax numbers If you need special accommodations due to a disability, please contact Doreen Brandes (see Contact Person) at least 7 days in advance. SUPPLEMENTARY INFORMATION: I. Criteria for Members FDA believes that persons nominated for membership as a consumer representative on the committee/panels should meet the following criteria: (1) Demonstrate ties to consumer and community-based organizations, (2) be able to analyze technical data, (3) understand research design, (4) be able to discuss benefits and risks, and (5) be able to evaluate the safety and efficacy of products under review. The consumer representative represents the consumer perspective on issues and actions before the advisory committee; serves as a liaison between the committee and interested consumers, associations, coalitions, and consumer organizations; and facilitates dialogue with the advisory committees on scientific issues that affect consumers. II. Nomination Procedures When individuals are nominated to serve as consumer representatives on FDA advisory committee and panels, all nominations should include a cover letter, a curriculum vita or resume (that includes the nominee’s office address, telephone number, and e-mail address), and a list of consumer or communitybased organizations for which the candidate can demonstrate active participation. Nominations will specify the advisory committee(s)or panel(s) for which the nominee is recommended. Any interested person or organization may nominate one or more qualified persons for membership as consumer representatives on the advisory committee/panels. Self-nominations are also accepted. Potential candidates will be required to provide detailed information concerning such matters as financial holdings, employment, and research grants and/or contracts to permit evaluation of possible sources of a conflict of interest. The nomination should specify the committees/panels of PO 00000 Frm 00047 Fmt 4703 Sfmt 4703 interest. The term of office is up to 4 years, depending on the appointment date. Additional background information regarding the topics for the public meeting will be available 5 days before the meeting and may be found at: https:// www.fda.gov/AdvisoryCommittees/ default.htm (look for link to Advisory Committee Public Meeting for Consumer Representatives.) Dated: March 24, 2010. Jill Hartzler Warner, Acting Associate Commissioner for Special Medical Programs. [FR Doc. 2010–6967 Filed 3–29–10; 8:45 am] BILLING CODE 4160–01–S DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Center for Scientific Review; Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: Center for Scientific Review Special Emphasis Panel; Member Conflict: BSCH. Date: April 1, 2010. Time: 3 p.m. to 4:30 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892 (Telephone Conference Call). Contact Person: Jose H. Guerrier, PhD, Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 5218, MSC 7852, Bethesda, MD 20892, 301–435– 1137, guerriej@csr.nih.gov. This notice is being published less than 15 days prior to the meeting due to the timing limitations imposed by the review and funding cycle. (Catalogue of Federal Domestic Assistance Program Nos. 93.306, Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333, 93.337, 93.393–93.396, 93.837–93.844, 93.846–93.878, 93.892, 93.893, National Institutes of Health, HHS) E:\FR\FM\30MRN1.SGM 30MRN1 Federal Register / Vol. 75, No. 60 / Tuesday, March 30, 2010 / Notices Dated: March 22, 2010. Jennifer Spaeth, Director, Office of Federal Advisory Committee Policy. [FR Doc. 2010–6957 Filed 3–29–10; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Center for Scientific Review; Notice of Closed Meetings jlentini on DSKJ8SOYB1PROD with NOTICES Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: Center for Scientific Review Special Emphasis Panel, Skeletal Degeneration and Repair. Date: April 16, 2010. Time: 4 p.m. to 5:30 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892. (Telephone Conference Call.) Contact Person: Daniel F. McDonald, PhD, Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 4110, MSC 7814, Bethesda, MD 20892. (301) 435– 1215. mcdonald@csr.nih.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel, Member Conflict: Neuroadaptations. Date: April 19–20, 2010. Time: 7 a.m. to 5 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892. (Virtual Meeting.) Contact Person: Bernard F. Driscoll, PhD, Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 5184, MSC 7844, Bethesda, MD 20892. (301) 435– 1242. driscolb@csr.nih.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel, PAR09–027: Raid Meeting. Date: April 20–21, 2010. Time: 11 a.m. to 5 p.m. Agenda: To review and evaluate grant applications. VerDate Nov<24>2008 16:22 Mar 29, 2010 Jkt 220001 Place: National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892. (Virtual Meeting.) Contact Person: Steven J. Zullo, PhD, Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 5146, MSC 7849, Bethesda, MD 20892. 301–435– 2810. zullost@csr.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.306, Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333, 93.337, 93.393–93.396, 93.837–93.844, 93.846–93.878, 93.892, 93.893, National Institutes of Health, HHS) Dated: March 22, 2010. Jennifer Spaeth, Director, Office of Federal Advisory Committee Policy. [FR Doc. 2010–6956 Filed 3–29–10; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute of Biomedical Imaging and Bioengineering; Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute of Biomedical Imaging and Bioengineering Special Emphasis Panel—PHASE II QUANTUM. Date: July 15, 2010. Time: 8 a.m. to 5 p.m. Agenda: To review and evaluate grant applications. Place: Bethesda Marriott Suites, 6711 Democracy Blvd., Bethesda, MD 20892. Contact Person: Ruth Grossman, DDS, Scientific Review Officer, National Institute of Biomedical Imaging and Bioengineering, 6707 Democracy Boulevard, Room 960, Bethesda, MD 20892, 301–496–8775, grossmanrs@mail.nih.gov. Dated: March 24, 2010. Jennifer Spaeth, Director, Office of Federal Advisory Committee Policy. [FR Doc. 2010–7123 Filed 3–29–10; 8:45 am] BILLING CODE 4140–01–P PO 00000 Frm 00048 Fmt 4703 Sfmt 4703 15715 DEPARTMENT OF HOMELAND SECURITY U.S. Citizenship and Immigration Services [CIS No. 2493–10; DHS Docket No. USCIS– 2010–0005] RIN 1615–ZA97 Filing Procedures and Automatic Extension of Employment Authorization and Related Documentation for Liberians Provided Deferred Enforced Departure AGENCY: U.S. Citizenship and Immigration Services, Department of Homeland Security. ACTION: Notice. SUMMARY: On March 18, 2010, President Obama issued a memorandum to the Secretary of Homeland Security (the Secretary), Janet Napolitano, directing the Secretary to extend for an additional 18 months the deferred enforced departure (DED) of certain Liberians and to provide for work authorization during that period. The extension runs from April 1, 2010, through September 30, 2011. This notice announces an automatic 6-month extension of current employment authorization documents (EADs) held by Liberians whose DED has been extended under the presidential memorandum and informs eligible Liberians and their employers how to determine which EADs are automatically extended. This notice also provides instructions for eligible Liberians on how to apply for the full 18-month extension of employment authorization. Finally, this notice provides instructions for DED-eligible Liberians on how to apply for permission to travel outside the United States during the 18-month DED period. DATES: This notice is effective April 1, 2010. The 6-month automatic extension of employment authorization for Liberians who are eligible for DED, including the extension of their EADs, as specified in this notice, is effective on April 1, 2010. This automatic extension will expire on September 30, 2010. The 18-month extension of DED is valid through September 30, 2011. FOR FURTHER INFORMATION CONTACT: • For further information on DED, including guidance on the application process for employment authorization and additional information on eligibility, please visit the USCIS Web site at https://www.uscis.gov. Under the heading ‘‘Humanitarian’’ select ‘‘Temporary Protected Status’’ from the homepage. You can then choose the DED page or the Liberian-specific page. E:\FR\FM\30MRN1.SGM 30MRN1

Agencies

[Federal Register Volume 75, Number 60 (Tuesday, March 30, 2010)]
[Notices]
[Pages 15714-15715]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2010-6957]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Center for Scientific Review; Notice of Closed Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. App.), notice is hereby given of the following 
meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel; Member Conflict: BSCH.
    Date: April 1, 2010.
    Time: 3 p.m. to 4:30 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, 6701 Rockledge Drive, 
Bethesda, MD 20892 (Telephone Conference Call).
    Contact Person: Jose H. Guerrier, PhD, Scientific Review 
Officer, Center for Scientific Review, National Institutes of 
Health, 6701 Rockledge Drive, Room 5218, MSC 7852, Bethesda, MD 
20892, 301-435-1137, guerriej@csr.nih.gov.
    This notice is being published less than 15 days prior to the 
meeting due to the timing limitations imposed by the review and 
funding cycle.

(Catalogue of Federal Domestic Assistance Program Nos. 93.306, 
Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333, 
93.337, 93.393-93.396, 93.837-93.844, 93.846-93.878, 93.892, 93.893, 
National Institutes of Health, HHS)


[[Page 15715]]


    Dated: March 22, 2010.
Jennifer Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 2010-6957 Filed 3-29-10; 8:45 am]
BILLING CODE 4140-01-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.